{
    "Trade/Device Name(s)": [
        "iGlucose Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K161790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K143387"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "March 23, 2017",
    "Summary Letter Received Date": "March 29, 2017",
    "Submission Date": "September 9, 2016",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Fingerstick",
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "iGlucose Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Oxidase electrochemical sensor",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Lancing Device",
        "Control Solution",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Bionime iGlucose Blood Glucose Monitoring System using oxidase electrochemical sensor for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips by a single user for self-monitoring diabetes control; not for diabetes diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}